Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 361: Which one of the following drugs does not produce central anticholinergic syndrome?

A. Atropine sulphate
B. Glycopyrrolate (Correct Answer)
C. Antihistaminics
D. Tricyclic antidepressants

Explanation: The **Central Anticholinergic Syndrome (CAS)** is caused by the blockade of muscarinic receptors in the brain, leading to symptoms such as confusion, agitation, hallucinations, and delirium. The primary factor determining whether an anticholinergic drug causes these symptoms is its ability to cross the **blood-brain barrier (BBB)**. [1] **Why Glycopyrrolate is the correct answer:** Glycopyrrolate is a **quaternary ammonium compound**. Due to its permanent positive charge (ionization), it is highly polar and lipid-insoluble. This prevents it from crossing the BBB in significant amounts. Consequently, it lacks central nervous system (CNS) effects and does not produce CAS. It is preferred in anesthesia when peripheral muscarinic blockade is needed without sedation or cognitive impairment. **Analysis of incorrect options:** * **Atropine sulphate:** This is a **tertiary amine**. Unlike quaternary compounds, tertiary amines are non-ionized and lipid-soluble, allowing them to easily cross the BBB and trigger CAS, especially in elderly patients or at high doses. [1] * **Antihistaminics:** First-generation H1-blockers (e.g., Diphenhydramine, Promethazine) are lipophilic tertiary amines with significant central anticholinergic activity, often leading to sedation and delirium. * **Tricyclic Antidepressants (TCAs):** Drugs like Amitriptyline have potent muscarinic antagonist properties. In overdose, they are classic causes of central anticholinergic toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Quaternary amines (Glycopyrrolate, Ipratropium, Tiotropium) stay **"Quartered"** outside the brain; Tertiary amines (Atropine, Scopolamine) **"Trespass"** into the brain. [1] * **Treatment of CAS:** The drug of choice is **Physostigmine** (a tertiary amine acetylcholinesterase inhibitor) because it can cross the BBB to reverse central symptoms. Neostigmine (quaternary) cannot. * **Scopolamine (Hyoscine):** More potent CNS depressant than atropine; often used for motion sickness but frequently causes sedation. [1]

Question 362: Which of the following is a short-acting non-depolarizing neuromuscular blocker?

A. Rocuronium
B. Suxamethonium
C. Mivacurium (Correct Answer)
D. Pancuronium

Explanation: **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action (Depolarizing vs. Non-depolarizing) and their duration of action. **Why Mivacurium is correct:** **Mivacurium** is the only **short-acting** non-depolarizing NMB (duration: 15–20 minutes). Like Suxamethonium, it is metabolized by **plasma pseudocholinesterase**, which accounts for its rapid clearance. It is often used for short procedures where rapid recovery of muscle function is required. **Analysis of Incorrect Options:** * **Rocuronium (Option A):** This is an **intermediate-acting** non-depolarizing NMB (duration: 30–40 minutes). It is notable for having the fastest onset of action among non-depolarizing agents, making it an alternative for rapid sequence intubation. * **Suxamethonium (Option B):** While it is short-acting, it is a **depolarizing** NMB. The question specifically asks for a *non-depolarizing* agent. * **Pancuronium (Option C):** This is a **long-acting** non-depolarizing NMB (duration: >60 minutes). It is known for its vagolytic effect, which can cause tachycardia. **High-Yield NEET-PG Pearls:** 1. **Classification by Duration:** * **Short-acting:** Mivacurium. * **Intermediate-acting:** Vecuronium, Atracurium, Cisatracurium, Rocuronium. * **Long-acting:** Pancuronium, Doxacurium, Pipecuronium. 2. **Hoffman Elimination:** Atracurium and Cisatracurium undergo spontaneous degradation in the plasma (independent of renal/hepatic function), making them the drugs of choice in **liver or kidney failure**. 3. **Adverse Effect:** Mivacurium can cause **histamine release**, leading to hypotension and flushing if injected rapidly. 4. **Reversal:** Non-depolarizing blockers are reversed by Neostigmine (acetylcholinesterase inhibitor) or Sugammadex (specifically for Rocuronium/Vecuronium).

Question 363: Which of the following is the only non-catecholamine sympathomimetic drug?

A. Adrenaline
B. Ephedrine (Correct Answer)
C. Dopamine
D. Isoprenaline

Explanation: ### Explanation The classification of sympathomimetic drugs is based on their chemical structure, specifically the presence or absence of a **catechol nucleus** (a benzene ring with hydroxyl groups at the 3 and 4 positions). **1. Why Ephedrine is the Correct Answer:** **Ephedrine** is a **non-catecholamine**. It lacks the hydroxyl groups on the benzene ring. This structural difference has three major clinical implications: * **Oral Bioavailability:** It is not destroyed by COMT (Catechol-O-methyltransferase), making it effective when taken orally. * **CNS Penetration:** Being more lipid-soluble, it crosses the blood-brain barrier. * **Duration of Action:** It has a significantly longer half-life than catecholamines. Additionally, Ephedrine acts via a **mixed mechanism** (directly stimulating $\alpha$ and $\beta$ receptors and indirectly by displacing norepinephrine from storage vesicles). **2. Why the Other Options are Incorrect:** * **Adrenaline (Epinephrine):** A naturally occurring endogenous catecholamine. It is the drug of choice for anaphylactic shock. * **Dopamine:** An endogenous catecholamine and a precursor to norepinephrine. It acts on D1, $\beta$1, and $\alpha$ receptors in a dose-dependent manner. * **Isoprenaline:** A synthetic catecholamine that acts as a pure $\beta$-agonist ($\beta$1 and $\beta$2). **3. High-Yield NEET-PG Pearls:** * **Tachyphylaxis:** Ephedrine is notorious for causing tachyphylaxis (rapidly diminishing response) with repeated doses due to the depletion of norepinephrine stores. * **Clinical Use:** Ephedrine is frequently used to manage hypotension during spinal anesthesia. * **Mnemonic:** Catecholamines (**D**opamine, **E**pinephrine, **N**orepinephrine, **I**soprenaline, **D**obutamine) = **DENID**. If it’s not on this list, it’s likely a non-catecholamine (e.g., Amphetamine, Phenylephrine, Salbutamol).

Question 364: What are the effects of α-adrenoreceptor stimulation?

A. Vasoconstriction (Correct Answer)
B. Vasodilation
C. Bronchoconstriction
D. Bronchodilation

Explanation: The correct answer is **A. Vasoconstriction**.The effects of adrenergic drugs are determined by the specific receptor subtype they stimulate. Adrenoreceptors are broadly divided into $\alpha$ and $\beta$ receptors.1. Why Vasoconstriction is Correct:$\alpha_1$-adrenoreceptors are primarily located on the **vascular smooth muscle** of resistance vessels (arterioles) in the skin, mucous membranes, and splanchnic area. Stimulation of these receptors leads to an increase in intracellular calcium via the $G_q$ protein-phospholipase C pathway, resulting in contraction of the smooth muscle, which manifests as **vasoconstriction** [1, 2]. This increases peripheral vascular resistance and raises blood pressure [2].2. Why Incorrect Options are Wrong:* **B. Vasodilation:** This is primarily mediated by **$\beta_2$-receptors** (found in skeletal muscle blood vessels) [2] or through the release of Nitric Oxide via M3 muscarinic receptors.* **C. Bronchoconstriction:** This is a parasympathetic effect mediated by **M3 receptors**. $\alpha$-stimulation has no significant effect on bronchial smooth muscle tone [2].* **D. Bronchodilation:** This is a classic **$\beta_2$-receptor** mediated effect [2]. Drugs like Salbutamol act on these receptors to relax bronchial smooth muscle.High-Yield Clinical Pearls for NEET-PG:* **$\alpha_1$ Receptors:** Think "Constriction" (Vasoconstriction, Mydriasis via dilator pupillae, and contraction of the bladder internal sphincter) [1, 2].* **$\alpha_2$ Receptors:** Primarily **presynaptic**; their stimulation inhibits the release of Norepinephrine (Negative feedback) [1, 2].* **Clinical Application:** Phenylephrine is a selective $\alpha_1$ agonist used as a nasal decongestant (due to vasoconstriction) and a mydriatic.* **Reversal of Action:** The "Dale’s Vasomotor Reversal" phenomenon occurs when $\alpha$-blockers are given before Adrenaline, leaving the $\beta_2$-mediated vasodilation unopposed, causing a fall in blood pressure.

Question 365: A child on Beta-2 agonists for the treatment of bronchial asthma may exhibit all of the following features EXCEPT:

A. Tremors
B. Hypoglycemia (Correct Answer)
C. Hypokalemia
D. Bronchodilation

Explanation: **Explanation:** Beta-2 agonists (e.g., Salbutamol, Terbutaline) act on $\beta_2$ receptors located throughout the body. The correct answer is **Hypoglycemia** because $\beta_2$ stimulation actually causes **Hyperglycemia**. **1. Why Hypoglycemia is the correct answer (The Exception):** Stimulation of $\beta_2$ receptors in the liver and skeletal muscle promotes **glycogenolysis** (breakdown of glycogen to glucose) and **gluconeogenesis**. Additionally, $\beta_2$ receptors on pancreatic islet cells increase insulin secretion, but the overall metabolic effect is an increase in blood glucose levels. Therefore, hypoglycemia is not a side effect; hyperglycemia is. **2. Analysis of Incorrect Options:** * **Tremors (Option A):** This is the **most common side effect**. It occurs due to the direct stimulation of $\beta_2$ receptors in the skeletal muscles. * **Hypokalemia (Option B):** $\beta_2$ agonists stimulate the $Na^+/K^+$ ATPase pump, causing an intracellular shift of potassium. This leads to decreased serum potassium levels. (Clinical Note: Salbutamol is sometimes used as an emergency treatment for hyperkalemia). * **Bronchodilation (Option D):** This is the primary therapeutic effect. $\beta_2$ receptors in the bronchial smooth muscle increase cAMP, leading to muscle relaxation and airway opening. **High-Yield Clinical Pearls for NEET-PG:** * **Muscle Tremors** are the dose-limiting side effect of oral $\beta_2$ agonists. * **Tachycardia** can occur due to direct $\beta_1$ stimulation (at high doses) or reflex tachycardia via $\beta_2$ mediated vasodilation. * **Tolerance (Tachyphylaxis):** Prolonged use leads to down-regulation of $\beta_2$ receptors. * **Drug of Choice:** Inhaled Short-Acting Beta Agonists (SABA) are the DOC for acute asthma exacerbations.

Question 366: Acetylcholinesterase inhibitors are not used in which of the following conditions?

A. Anticholinergic poisoning
B. Carbamate poisoning (Correct Answer)
C. Cobra bite
D. Glaucoma

Explanation: **Explanation:** The core concept here is the mechanism of action of **Acetylcholinesterase (AChE) inhibitors**. These drugs work by inhibiting the enzyme that breaks down acetylcholine, thereby increasing the concentration of acetylcholine at the synapse [1]. **Why Carbamate Poisoning is the Correct Answer:** Carbamates (like Carbaryl or Propoxur) are themselves **reversible inhibitors of AChE**. In carbamate poisoning, the enzyme is already inhibited, leading to a cholinergic crisis (SLUDGE symptoms). Administering another AChE inhibitor (like Neostigmine or Physostigmine) would further inhibit any remaining enzyme, worsening the toxicity and exacerbating the cholinergic crisis. Therefore, they are strictly contraindicated. The treatment of choice is Atropine. **Analysis of Incorrect Options:** * **Anticholinergic Poisoning:** Physostigmine (a tertiary amine AChE inhibitor) is the specific antidote for Atropa belladonna or Datura poisoning because it crosses the blood-brain barrier to reverse both central and peripheral anticholinergic effects. * **Cobra Bite:** Cobra venom contains post-synaptic neurotoxins that block nicotinic receptors (Nm) at the neuromuscular junction. AChE inhibitors like Neostigmine increase acetylcholine levels to outcompete the toxin, helping reverse paralysis [2]. * **Glaucoma:** Topical AChE inhibitors (e.g., Echothiophate, though rarely used now) cause miosis and contraction of the ciliary muscle, facilitating the drainage of aqueous humor and reducing intraocular pressure. **High-Yield Clinical Pearls for NEET-PG:** 1. **Oximes (Pralidoxime):** These are used in Organophosphate poisoning but are **not** used in Carbamate poisoning because the carbamylated enzyme does not undergo "aging" and oximes may actually worsen carbamate toxicity [3]. 2. **Physostigmine vs. Neostigmine:** Physostigmine crosses the BBB (Tertiary amine); Neostigmine does not (Quaternary ammonium). 3. **Edrophonium:** A very short-acting AChE inhibitor used in the **Tensilon test** for Myasthenia Gravis diagnosis [2].

Question 367: Which of the following is NOT associated with beta-2 agonist treatment?

A. Hyperkalemia (Correct Answer)
B. Hyperglycemia
C. Detrusor relaxation
D. Relaxation of gut and bronchial muscles

Explanation: **Explanation:**Beta-2 ($eta_2$) agonists act on G-protein coupled receptors to stimulate various physiological responses. The correct answer is **Hyperkalemia** because $eta_2$ agonists actually cause **hypokalemia**.**1. Why Hyperkalemia is the correct choice (The "NOT" factor):**$eta_2$ receptors stimulate the **Na+/K+ ATPase pump** in skeletal muscles. This causes an influx of potassium from the extracellular fluid into the cells. Consequently, serum potassium levels decrease (**Hypokalemia**). This effect is clinically utilized to treat emergency hyperkalemia (e.g., nebulized Salbutamol) [2].**2. Analysis of Incorrect Options:*** **B. Hyperglycemia:** $eta_2$ stimulation in the liver promotes **glycogenolysis** and **gluconeogenesis**. It also increases glucagon release from the pancreas, leading to elevated blood glucose levels [2].* **C. Detrusor relaxation:** While $eta_3$ receptors are the primary mediators of detrusor relaxation (e.g., Mirabegron), $eta_2$ receptors also contribute to the relaxation of the bladder wall (detrusor muscle), aiding in urine storage.* **D. Relaxation of gut and bronchial muscles:** $eta_2$ agonists cause smooth muscle relaxation via increased cAMP. This leads to **bronchodilation** (the primary use in asthma/COPD) and decreased gastrointestinal motility [1].**High-Yield Clinical Pearls for NEET-PG:** * **Tocolysis:** $eta_2$ agonists like **Ritodrine** and **Terbutaline** are used to relax the uterus and delay premature labor.* **Tremors:** The most common side effect of $eta_2$ agonists is muscle tremors, caused by direct action on $eta_2$ receptors in skeletal muscles.* **Tachycardia:** Even "selective" $eta_2$ agonists can cause tachycardia due to reflex sympathetic stimulation (vasodilation) and minor cross-reactivity with cardiac $eta_1$ receptors.

Question 368: Clinical signs of atropine intoxication are as follows, EXCEPT:

A. Decreased bowel sounds
B. Dry skin
C. Scarlet flushing of face
D. Increased bowel sounds (Correct Answer)

Explanation: **Explanation:** Atropine is a competitive antagonist of muscarinic acetylcholine receptors. The clinical signs of atropine intoxication (anticholinergic toxicity) result from the blockade of the parasympathetic nervous system, leading to a "systemic drying" and "slowing" effect. **Why "Increased bowel sounds" is the correct answer:** The parasympathetic nervous system (via the Vagus nerve) normally increases gastrointestinal motility. Atropine blocks these M3 receptors in the gut, leading to **decreased intestinal motility** and constipation. Therefore, **decreased or absent bowel sounds** are expected; "Increased bowel sounds" is physiologically inconsistent with anticholinergic action. **Analysis of Incorrect Options:** * **Decreased bowel sounds:** This is a classic sign of atropine toxicity due to smooth muscle relaxation in the GI tract. * **Dry skin:** Atropine blocks M3 receptors on eccrine sweat glands (which are innervated by sympathetic cholinergic fibers). This leads to anhidrosis (suppression of sweating) and dry, hot skin. * **Scarlet flushing of face:** Known as "Atropine flush," this occurs due to compensatory cutaneous vasodilation in the blush area to dissipate heat, as the body cannot sweat. **NEET-PG High-Yield Pearls:** To remember atropine poisoning, use the classic mnemonic: * **Red as a beet:** Flushing due to vasodilation. * **Dry as a bone:** Dry skin and mouth (decreased secretions). * **Blind as a bat:** Mydriasis (dilated pupils) and cycloplegia (loss of accommodation). * **Mad as a hatter:** Delirium, hallucinations, and agitation. * **Hot as a hare:** Hyperpyrexia (especially in children). **Drug of Choice for Atropine Poisoning:** **Physostigmine** (a tertiary amine acetylcholinesterase inhibitor that crosses the blood-brain barrier).

Question 369: The action of adrenaline is potentiated in the presence of all the following anesthetics except:

A. Halothane
B. Ethyl chloride
C. Cyclopropane
D. Ether (Correct Answer)

Explanation: **Explanation:** The core concept behind this question is **Myocardial Sensitization to Catecholamines**. Certain volatile anesthetics sensitize the myocardium to the arrhythmogenic effects of adrenaline (epinephrine), increasing the risk of ventricular arrhythmias. **1. Why Ether is the Correct Answer:** Ether is a **non-sensitizing** anesthetic. Unlike halogenated agents, ether does not sensitize the heart to adrenaline. In fact, ether causes a reflex increase in sympathetic activity, which actually supports blood pressure and heart rate without making the myocardium hyper-reactive to exogenous adrenaline. Therefore, the action of adrenaline is not potentiated (in terms of arrhythmia risk) by ether. **2. Analysis of Incorrect Options:** * **Halothane:** This is the "classic" sensitizer. It is highly potent in sensitizing the heart to catecholamines. Using adrenaline with halothane is strictly limited to avoid fatal ventricular fibrillation. * **Ethyl chloride:** This is an older, halogenated hydrocarbon that, like halothane, significantly sensitizes the myocardium to adrenaline. * **Cyclopropane:** Although not a halogenated gas, cyclopropane is notorious for its high potential to sensitize the heart to adrenaline, often leading to serious arrhythmias. **3. NEET-PG High-Yield Pearls:** * **Order of Sensitization:** Halothane > Cyclopropane > Trichloroethylene > Ethyl chloride. * **Modern Agents:** Isoflurane, Desflurane, and Sevoflurane have much lower sensitization potential compared to Halothane, making them safer for use when adrenaline is needed (e.g., for local hemostasis). * **Clinical Rule:** If adrenaline must be used with Halothane, the dose should not exceed **1 µg/kg**. * **Thiopentone:** It is also considered non-sensitizing to the myocardium.

Question 370: Which of the following drugs has the maximum risk of causing dry mouth?

A. Oxybutynin (Correct Answer)
B. Trospium
C. Solifenacin
D. Flavoxate

Explanation: **Explanation:** The question tests your knowledge of the selectivity and pharmacokinetics of **Overactive Bladder (OAB)** drugs. **1. Why Oxybutynin is the Correct Answer:** Oxybutynin is a non-selective muscarinic antagonist. Its high incidence of dry mouth (xerostomia) is due to two main factors: * **Lack of Receptor Selectivity:** It blocks $M_1$, $M_2$, and $M_3$ receptors. The blockade of $M_3$ receptors in the salivary glands leads to decreased secretions. * **Active Metabolite:** It is extensively metabolized in the liver and gut wall to **N-desethyloxybutynin**, which has a very high affinity for parotid gland receptors. This metabolite reaches much higher systemic levels than the parent drug, significantly increasing the side-effect profile. **2. Why Other Options are Incorrect:** * **Trospium:** It is a **quaternary ammonium compound**. Because it is polar, it has poor systemic absorption and does not cross the blood-brain barrier easily. It generally has a lower side-effect profile compared to oxybutynin. * **Solifenacin:** This is a **long-acting, $M_3$-selective antagonist**. Because it is more specific for the bladder $M_3$ receptors over the salivary $M_3$ receptors, it causes significantly less dry mouth. * **Flavoxate:** It acts primarily as a direct smooth muscle relaxant (PDE inhibition and Calcium channel blockade) rather than a pure anticholinergic. It is clinically less effective for OAB but also has a lower incidence of classical anticholinergic side effects. **3. NEET-PG High-Yield Pearls:** * **M3 Selectivity:** Solifenacin and Darifenacin are the most $M_3$-selective agents (Lower dry mouth risk). * **Lipophilicity:** Oxybutynin is highly lipophilic and crosses the BBB, frequently causing **cognitive impairment/confusion** in the elderly. * **Alternative:** **Mirabegron** (a $\beta_3$ agonist) is now preferred for OAB in patients who cannot tolerate anticholinergic side effects like dry mouth or constipation.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free